Amphastar Pharmaceuticals, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2019
Total Assets: $587.0M
Liabilities Breakdown FY2019
Total Liabilities: $159.4M
Asset Breakdown
Total Assets: $587.0M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $73.7M | 12.6% |
| Accounts Receivable | $45.4M | 7.7% |
| Inventory | $110.5M | 18.8% |
| Property, Plant & Equipment | $233.9M | 39.8% |
| Goodwill | $3.6M | 0.6% |
| Intangible Assets | $8.3M | 1.4% |
| Other Assets | $111.6M | 19.0% |
Liabilities Breakdown
Total Liabilities: $159.4M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $25.1M | 15.7% |
| Long-Term Debt | $46.3M | 29.1% |
| Other Liabilities | $88.1M | 55.2% |